Ortie Capital Investment S.A. is a private equity and venture capital fund. The core activity of the fund are investments in companies and partnerships in an early stage of development (seed stage) and in their initial stage of operation (start-up).
We make small investments in enterprises which are still at their formation stage, when financial and management support are equally necessary. It allows us to become a partner who speeds up development of the company and respects the independence of its present owners and originators as far as project implementation is concerned.
  • Ortie invests into businesses in the following fields:
  • medical services,
  • production of medical equipment,
  • health protection,
  • pharmaceutics,
  • sport and recreation,
  • logistics,
  • financial services.

The value of the portfolio is increased by providing financial means necessary for project’s development, as well as business and trade support. Investments made by Ortie Capital Investment S.A. in new projects vary from PLN 300,000 to 3,000,000 for the average term of up to 3 years.

Investment criteria

Ortie invests into businesses in the following fields:

medical services,
production of medical equipment,
health protection,
financial services.
Ortie uses a number of criteria which facilitate making investing decisions. While analysing a company we check:
  • if it operates within an industry that conforms to the fund investing strategy,
  • if its business is innovative,
  • what is the experience of managers and others involved
  • if its products or services are insensitive to state regulations,
  • if it has been on the market for at least 9 months.

What you can benefit

What can Ortie Capital Investment ofer to enterpreneurs?
  • support in creating an efficient and effective organization,
  • capital provided without interest at an early stage of the company’s (or enterprise) life cycle,
  • shorter time of product or service market launch,
  • guarantee of management quality consistent with business ethics for our present and future contractors,
  • increased financial credibility,
  • autonomy of the present management board (business leaders) in implementing their strategy,
  • management buyout option.

Our investments

Nettle is an operator of outsourcing services for companies from the pharmaceutical sector. It specializes in the management of receivables, offering a range of financial products, and assists in the sales activities of its customers.

In 2014, together with two partners, the company initiated and implemented Poland’s first full direct distribution service (DTP) for a large international pharmaceutical company. As part of DTP, the company offers manufacturers of pharmaceuticals a whole range of services – from the organization of the sales process (including call center, preparation of tenders, a dedicated billing centre) to financing receivables and accounting for all operations.

Within the framework of its activities, Nettle has financed more than 2,100 contracts for an amount exceeding PLN 600 million, and manages 10 thousand portfolios of recipients on an ongoing basis (including nearly 600 hospitals). Until 2014, the company supported the receivables of pharmaceutical companies for the amount of PLN 2.4 million.

In 2015, Nettle exceeded the threshold of 2 billion 400 million PLN of receivables managed solely in the health care sector. By funding medical equipment, Nettle also helps in implementing new technologies in hospitals. In 2014, Nettle was announced a finalist of one of the most prestigious business competitions in Europe – EUROPEAN BUSINESS AWARDS, winning the title of National Champion.

Asclepios is a pharmaceutical wholesaler, existing since 1995. After the acquisition of the company by the Investment Fund Ortie in 2008, Asclepios became a nationwide wholesaler with a modern organizational and management structure. The core of the company is the commercial departments. Other services were entrusted to external partners.

Asclepios currently works with most hospitals in Poland. The company’s partners are the largest suppliers to the medical market, so the company can offer all pharmaceuticals for inpatient care available in Poland. It also conducts independent import of hospital drugs.

In 2014, Asclepios reached a turnover of almost PLN 300 million, and joined up to 1700 tender proceedings.

Asclepios has won many prestigious national awards – several times the Business Gazele and Forbes Diamonds.

The company RBO provides a wide range of IT and telecommunications services. It addresses its offer to companies operating in various industries. It provides them with the most advanced solutions for improving work in the enterprise, thus increasing competitiveness on the market.

RBO’s offer also includes traditional IT services, such as configuration, installation and administration of computer hardware, or equipment rental, as well as innovative solutions, among which VoIP telecommunications deserves attention or author applications designed for enterprises from different industries. Customers can choose from a wide range of services that suit their needs most. The right IT facilities allow every company, regardless of its profile, to streamline business processes, while making significant savings.

RBO is a recipient of numerous awards and distinctions, among others: Best Quality 2015, Computerworld TOP200, Deloitte Technology Fast 50 Central Europe 2014.

Investments implemented:

Logistics company Poltraf – specialized in the organization and operation of direct distribution of products from the pharmaceutical industry and related industries, operating on the hospital or pharmaceutical market. The activities of the company have been divided into three basic groups:
  1. Comprehensive support of the sales of products from the pharmaceutical sector
  2. Nationwide distribution of medicinal products, dressing products and medical goods
  3. Storage and consignment of medicinal and dressing products
On a daily basis, Poltraf works with over 180 manufacturers and distributors of medicinal products, medical goods, dressing products, dietary supplements and cosmetics. It executes more than 76 000 deliveries per month. The company is located in Błonie near Warsaw, where one of the three consignment warehouses is located.

In March 2015, a sales contract of Poltraf’s shares was finalized. The buyer of 100% of the shares is the international logistics company UPS from Atlanta, USA.

Stages of investment implementation

Initial analysis
The first step is to hand over to Ortie the investment project in a form of an enterprise description (attachment). After the first examination, Ortie assesses whether the project is consistent with the fund strategy, and then the initial risks tied to project’s implementation are estimated. During this stage meetings with project’s originators may be held
Assessment of the business plan
The second stage consists of the analysis of the complete business plan with detailed examination of the product or service, market profile and potential, assessment of the managing personnel and estimating the accuracy of financial forecasts set forth in the business plan.
In the case of a company still in its development stage, due diligence is carried out in its financial, organizational and legal fields.
Final assessment of the enterprise and setting forth investment terms
On the grounds of the assessment of the company and its executive personnel, the fund decides to accept or turn down the project. If the project has been accepted by the fund, investment terms are determined and set forth in the investment agreement. Once the agreement has been signed, the capital is transferred and the transaction is closed.
The complete investment process – from the moment of handing over essential materials and data to Ortie to paying the money into the company’s bank account – can take from 1.5 to 3 months, depending on the attitude of the business leaders as well as on the flow of documents and information.
Post-investment cooperation
The decision to invest capital into a company means entering into cooperation based on mutual trust and respect of each other’s interest. In addition to equity links, the funds are connected with the company also by the person of the Ortie investment director, who represents them in the supervisory board, and simultaneously is a partner in the company’s management board, where he advises on key decisions. Companies are obliged to report regularly, most often monthly and according to a set pattern, which allows to identify deteriorating conditions or any other irregularities at an early stage. Every year companies prepare the budget for the next year, which has to be approved by their supervisory board and which serves as a basis to assess the operation of the company and its management.
Main areas of cooperation with the company
  • Assistance in drawing up strategies, business plans and financial plans;
  • Consultancy on drawing up and implementing investment plans, as well as selecting, assessing and acquiring financial sources and instruments;
  • Supporting the company in transforming its organizational and corporate structure during the stage of dynamic growth and development;
  • Assistance in finding and negotiating with key investor.
Making an exit from the investment
The terms of an exit of the fund from a particular investment are pre-determined in the investment agreement. The decision takes into account the development stage of the company, its profile, the profile of the company’s trade and economic situation. It is important that after Ortie has made its exit, new investor continues company’s strategy, further increasing its value.
As Ortie invests into enterprises at an early development stage and plans to finish the investment within 3 years, the preferred form of exit is selling shares to the present management (management buyout) or selling them to other venture capital fund which invests in companies at more advanced stages of development.
The process of making an exit from the investment is conducted with the assistance of an experienced and qualified consultant, specializing in servicing medium size transactions.

Management Board

Paweł Szewczyk
Member of the Board

Krzysztof Wojtas
President of the Management Board

Piotr Król
Member of the Board

Contact

Dynamic entrepreneurs and business originators are invited to cooperate. Please, address the mail concerning the need for financial means for implementing new projects to: biuro@ortie.pl

Phone
+ 48 71 769 81 88
+ 48 71 769 84 10

Ortie Capital Investment S.A.
ul. Hubska 44
50-502 Wrocław
To Top